Trials / Completed
CompletedNCT03164187
Evaluation of Type 2 Diabetes Treatment
Evaluation of Type 2 Diabetes Treatment in AZERbaijan
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 105 (actual)
- Sponsor
- Servier Affaires Médicales · Industry
- Sex
- All
- Age
- 35 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to analyze the efficacy of Diabeton 60 MR as intensive sugar-lowering therapy into routine clinical practice, in patients for whom the treating physician has already decided to prescribe this medication. This concerns untreated newly diagnosed patients uncontrolled by diet, and patients uncontrolled by metformin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Diabeton 60 MR | Administer Diabeton MR 60 mg 1/2 tablet. Increasing dosage of Diabeton MR 60 mg by ½ tablet is recommended if fasting glucose level exceeds 6 mmol/L. |
Timeline
- Start date
- 2016-09-01
- Primary completion
- 2017-05-15
- Completion
- 2017-06-10
- First posted
- 2017-05-23
- Last updated
- 2024-07-25
Locations
4 sites across 1 country: Azerbaijan
Source: ClinicalTrials.gov record NCT03164187. Inclusion in this directory is not an endorsement.